Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 16 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| XBP1 | ENSG00000100219 | 0.00 | 0.00 | 0 | 0 |
| JOSD1 | ENSG00000100221 | 0.00 | 0.00 | 0 | 0 |
| CYB5R3 | ENSG00000100243 | 0.00 | 0.23 | 0 | 1 |
| HMOX1 | ENSG00000100292 | 0.00 | 0.00 | 0 | 0 |
| ARSA | ENSG00000100299 | 0.00 | 1.30 | 0 | 6 |
| TSPO | ENSG00000100300 | 0.00 | 0.00 | 0 | 0 |
| ACR | ENSG00000100312 | 0.00 | 0.00 | 0 | 0 |
| APOL1 | ENSG00000100342 | 0.00 | 0.00 | 0 | 0 |
| TXN2 | ENSG00000100348 | 0.00 | 0.00 | 0 | 0 |
| CSF2RB | ENSG00000100368 | 0.00 | 0.00 | 0 | 0 |
| UPK3A | ENSG00000100373 | 0.00 | 0.00 | 0 | 0 |
| CHADL | ENSG00000100399 | 0.00 | 0.00 | 0 | 0 |
| KCNK10 | ENSG00000100433 | 0.00 | 0.11 | 0 | 1 |
| CTSG | ENSG00000100448 | 0.00 | 0.00 | 0 | 0 |
| GZMH | ENSG00000100450 | 0.00 | 0.00 | 0 | 0 |
| GZMB | ENSG00000100453 | 0.00 | 0.00 | 0 | 0 |
| PRMT5 | ENSG00000100462 | 0.27 | 0.00 | 1 | 0 |
| CDKN3 | ENSG00000100526 | 0.00 | 0.00 | 0 | 0 |
| GSTZ1 | ENSG00000100577 | 0.00 | 0.38 | 0 | 2 |
| LGMN | ENSG00000100600 | 0.00 | 0.31 | 0 | 1 |
|
Showing page 16 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.